Cyclo Therapeutics, Inc. logo

Cyclo Therapeutics, Inc.

NASDAQ:CYTH

Overview | Financials
Company Name Cyclo Therapeutics, Inc.
Symbol CYTH
Currency USD
Price 0.647
Market Cap 18,557,703
Dividend Yield 0%
52-week-range 0.59 - 2.12
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. N. Scott Fine
Website https://www.cyclotherapeutics.com

An error occurred while fetching data.

About Cyclo Therapeutics, Inc.

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment

Related Stocks

InspireMD, Inc. logo

InspireMD, Inc.

NSPR

2.724 USD

Forte Biosciences, Inc. logo

Forte Biosciences, Inc.

FBRX

7.28 USD

Inspira Technologies Oxy B.H.N. Ltd. logo

Inspira Technologies Oxy B.H.N. Ltd.

IINN

1.21 USD

Nephros, Inc. logo

Nephros, Inc.

NEPH

1.862 USD

Financials

Numbers are in millions USD

Numbers are in millions USD